Dr. Ira S. DuBey has over 25 years of senior executive experience managing and building science-based businesses. He is President, Pharmaceutical Development Services Division, and Chairman of the Advisory Board. In this capacity, he is responsible for the management of the business and continued growth strategy, and in ensuring that there is alignment between scientific expertise, operational excellence and business expansion into appropriate sectors.
Prior to Smithers, Dr. DuBey held the position of Vice President and General Manager of Biotechnology Services for Tandem Labs, Inc. a LabCorp Company. Dr. DuBey conceived and built the business at Tandem Labs that supported the development of large molecule drugs (biologics) and therapeutic vaccines. Prior to Tandem Labs, he held the position of Director of Immunochemistry Services for Covance Laboratories, Inc. In this capacity he was responsible for providing laboratory services that supported NIH work as well as the development of large molecule drugs, such as protein drugs and MAB drugs. The facility was both a GLP laboratory and CLIA certified and supported both pre-clinical and clinical development. Dr. DuBey holds an M.S. degree in Toxicology from the University of Maryland Graduate School, an M.B.A. from the Johns Hopkins University and a Ph.D. from the Graduate Center of CUNY.